Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Malaria Transmission Season in Healthy African Adult Women of Childbearing Potential in Mali
Clinical trial NCT03989102 · COMPLETED
Trial details
- NCT number
- NCT03989102
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-03
- Primary completion
- 2022-04-05
- Enrollment
- 324
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.